Ligand Pharmaceuticals Inc. Announces Board of Directors Changes

SAN DIEGO--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (the “Company” or “Ligand”) today announced changes to its Board of Directors team resulting from the Company’s recent acquisition of Pharmacopeia, Inc. (“Pharmacopeia”).